Source: Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Dhar, V. Jeebun, H. W. Clague (Sunderland, United Kingdom). CT scanning is an imperfect means of predicting pathological stage in lung cancer. Eur Respir J 2006; 28: Suppl. 50, 567

Member's Comments

No comment yet.

Related content which might interest you: CT-PET scanning in suspected lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004 The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 PET scan in stage IA lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 436s Year: 2007 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005 Modelling the cancer risk potentially associated with repetitive CT scanning in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer Source: Eur Respir J 2006; 28: 915-919 Year: 2006 PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=54 Year: 2004 The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 Comparison of standard mediastinoscopy and chest CT for precise staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 171s Year: 2005 Prediction of the lung adenocarcinoma metastatic spread according to initial CT examination Source: Annual Congress 2011 - Imaging in oncology and infectious diseases Year: 2011 The value of autofluorescence bronchoscopy in the pre-operative staging of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 525s Year: 2004 Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020 Year: 2021 Agreement between tumor measurement on computer tomography and resected specimen size in lung cancer Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 CT densitometry as a predictor of pulmonary function in lung cancer patients Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Role of CT guided lung biopsy in the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001 Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009